🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

According to the social media company, the platform has removed problematic material and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or administering at residence.

Within minutes of joining one community, a seller shared contact information, where most transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts display black plastic packages with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously seen patients harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly serious medical dangers”.